Divergent impact of Toll-like receptor 2 deficiency on repair mechanisms in healthy muscle versus Duchenne muscular dystrophy

The Journal of Pathology
Kamalika MojumdarB J Petrof

Abstract

Injury to skeletal muscle, whether acute or chronic, triggers macrophage-mediated innate immunity in a manner which can be either beneficial or harmful for subsequent repair. Endogenous ligands for Toll-like receptor 2 (TLR2) are released by damaged tissues and might play an important role in activating the innate immune system following muscle injury. To test this hypothesis, we compared macrophage behaviour and muscle repair mechanisms in mice lacking TLR2 under conditions of either acute (cardiotoxin-induced) or chronic (mdx mouse genetic model of Duchenne muscular dystrophy; DMD) muscle damage. In previously healthy muscle subjected to acute damage, TLR2 deficiency reduced macrophage numbers in the muscle post-injury but did not alter the expression pattern of the prototypical macrophage polarization markers iNOS and CD206. In addition, there was abnormal persistence of necrotic fibres and impaired regeneration in TLR2-/- muscles after acute injury. In contrast, TLR2 ablation in chronically diseased muscles of mdx mice not only resulted in significantly reduced macrophage numbers but additionally modified their phenotype by shifting from inflammatory (iNOS(pos) CD206(neg) ) to more anti-inflammatory (iNOS(neg) CD206(pos) ) ...Continue Reading

References

Oct 23, 1997·The Journal of Cell Biology·V StraubK P Campbell
Oct 3, 2001·The Journal of Cell Biology·M WehlingJ G Tidball
Dec 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marina A DobrovolskaiaStefanie N Vogel
Mar 26, 2003·The American Journal of Pathology·Reinhart SeiblRoger P Lauener
Apr 25, 2003·American Journal of Physiology. Cell Physiology·Yi-Ping Li
Dec 13, 2003·American Journal of Respiratory and Critical Care Medicine·Maziar DivangahiBasil J Petrof
Jan 13, 2004·Physiological Reviews·Sophie B P Chargé, Michael A Rudnicki
Jan 31, 2004·Seminars in Immunology·Kiyoshi Takeda, Shizuo Akira
Mar 17, 2004·Toxicon : Official Journal of the International Society on Toxinology·J B Harris
Jun 12, 2004·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Stefan MateckiBasil J Petrof
Sep 8, 2004·Neuromuscular Disorders : NMD·Alexandre BriguetJosef P Magyar
Dec 17, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Gordon L WarrenPetia P Simeonova
Apr 30, 2005·American Journal of Respiratory Cell and Molecular Biology·Alexandre DemouleBasil J Petrof
Jul 19, 2005·The Journal of Clinical Investigation·Liliana SchaeferHermann-Josef Gröne
Sep 17, 2005·The Journal of Clinical Investigation·Jaklien C LeemansSandrine Florquin
Jan 21, 2006·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Mukesh SummanPetia P Simeonova
May 9, 2007·The Journal of Experimental Medicine·Ludovic ArnoldBénédicte Chazaud
May 18, 2007·Annual Review of Cell and Developmental Biology·Dianhua JiangPaul W Noble
Dec 7, 2007·The Journal of Clinical Investigation·Shahla Abdollahi-RoodsazWim B van den Berg
Dec 29, 2007·The Journal of Pathology·X Zhang, D M Mosser
Feb 7, 2008·The Cochrane Database of Systematic Reviews·A Y ManzurA Swan
Jun 21, 2008·The Journal of Physiology·Linda YahiaouiBasil J Petrof
Oct 2, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Dongxu SunPaula K Shireman
Nov 26, 2008·Nature Reviews. Immunology·David M Mosser, Justin P Edwards
Apr 4, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Qi-Quan HuangRichard M Pope
May 20, 2009·The Journal of Clinical Investigation·Sylvia A VetroneMelissa J Spencer
Apr 10, 2010·Nature Reviews. Drug Discovery·Elizabeth J HennessyLuke A J O'Neill
Jul 16, 2010·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Carlo O MartinezPaula K Shireman
Nov 23, 2010·Nature Reviews. Immunology·Grace Y Chen, Gabriel Nuñez
Jan 12, 2011·Annual Review of Immunology·Ulf Andersson, Kevin J Tracey
Jun 24, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Haiyan LuLan Zhou
Nov 2, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Conrad A FarrarSteven H Sacks
Mar 2, 2012·The Journal of Clinical Investigation·Antonio Sica, Alberto Mantovani
Feb 7, 2013·The FEBS Journal·Marielle SaclierBénédicte Chazaud
Mar 8, 2013·Lancet·Eugenio Mercuri, Francesco Muntoni
May 22, 2013·Proceedings of the National Academy of Sciences of the United States of America·James W GodwinNadia A Rosenthal
Jul 17, 2013·The Journal of Pathology·Kitipong UaesoontrachoonKanneboyina Nagaraju

❮ Previous
Next ❯

Citations

Mar 10, 2016·The Journal of Pathology·Sajedah M Hindi, Ashok Kumar
Dec 1, 2009·Lancet Neurology·Katharine BushbyUNKNOWN DMD Care Considerations Working Group
Aug 8, 2018·Human Molecular Genetics·Roberta SaghedduGuglielmo Sorci
Aug 10, 2019·Stem Cells International·Junio DortNicolas A Dumont
Jul 13, 2019·Briefings in Bioinformatics·Mitra EbrahimpoorJelle Goeman
Sep 7, 2019·International Journal of Molecular Sciences·Chenglin MoMarco Brotto
Sep 24, 2021·Pflügers Archiv : European journal of physiology·Kay Ohlendieck, Dieter Swandulla

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here